CareDx, Inc
CDNA
$17.87
$0.060.34%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.72% | -6.06% | 17.54% | 32.04% | 23.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.72% | -6.06% | 17.54% | 32.04% | 23.35% |
| Cost of Revenue | 11.18% | 2.35% | 9.57% | 10.01% | 12.39% |
| Gross Profit | 25.47% | -9.73% | 22.02% | 46.16% | 29.66% |
| SG&A Expenses | 2.58% | 0.10% | -8.43% | 32.71% | -1.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.83% | -2.16% | -2.03% | 17.74% | 0.97% |
| Operating Income | 98.21% | -47.00% | 64.49% | 19.98% | 51.83% |
| Income Before Tax | 115.90% | -88.76% | 48.45% | 166.29% | 55.71% |
| Income Tax Expenses | -107.50% | -631.82% | 169.88% | 3.64% | 350.00% |
| Earnings from Continuing Operations | 115.75% | -85.33% | 47.94% | 166.06% | 54.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 115.75% | -85.33% | 47.94% | 166.06% | 54.71% |
| EBIT | 98.21% | -47.00% | 64.49% | 19.98% | 51.83% |
| EBITDA | 134.80% | -86.28% | 76.45% | 22.13% | 58.70% |
| EPS Basic | 115.86% | -78.10% | 51.31% | 164.97% | 53.61% |
| Normalized Basic EPS | 116.06% | -74.05% | 76.89% | 9.49% | 57.86% |
| EPS Diluted | 114.92% | -77.78% | 50.61% | 160.76% | 53.61% |
| Normalized Diluted EPS | 116.06% | -74.05% | 76.89% | 15.65% | 57.86% |
| Average Basic Shares Outstanding | -0.75% | 4.04% | 6.91% | 1.68% | -2.35% |
| Average Diluted Shares Outstanding | -0.75% | 4.04% | 6.91% | 9.05% | -2.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |